| dc.contributor.author | Pereira-Céspedes, Alfonso | |
| dc.contributor.author | Jiménez Morales, Alberto | |
| dc.contributor.author | Palomares-Bayo, Magdalena | |
| dc.contributor.author | Martínez Martínez, Fernando | |
| dc.contributor.author | Calleja Hernández, Miguel Ángel | |
| dc.date.accessioned | 2023-09-22T07:47:54Z | |
| dc.date.available | 2023-09-22T07:47:54Z | |
| dc.date.issued | 2023-08-02 | |
| dc.identifier.citation | Pereira-Céspedes, A.; Jiménez-Morales, A.; Palomares-Bayo, M.; Martínez-Martínez, F.; Calleja-Hernández, M.Á. Medication Review with Follow-Up for End-Stage Renal Disease: Drug-Related Problems and Negative Outcomes Associated with Medication—A Systematic Review. J. Clin. Med. 2023, 12, 5080. [https://doi.org/10.3390/jcm12155080] | es_ES |
| dc.identifier.uri | https://hdl.handle.net/10481/84574 | |
| dc.description | Financial support received as a Doctoral Grant [reference number OAICE-143-2020] from the Office of International Affairs and External Cooperation, University of Costa Rica. | es_ES |
| dc.description.abstract | Background: This article reviews the available scientific literature on drug-related problems and negative outcomes associated with medications identified by medication review with follow-up for end-stage renal disease and discussed with the physicians. Methods: A systematic review was conducted of the scientific literature retrieved from the following databases: MEDLINE (via PubMed), Web of Science, SCOPUS, Cochrane Library: The Cochrane Central Register and Control Trials (CENTRAL) and Literatura Latinoamericana y del Caribe (LILACS), Medicina en Español (MEDES), and the SciELO bibliographic database (a collection of scientific journals). The following terms were used as descriptors and searched in free text: “end-stage renal disease”, “medication review”, “drug-related problems”, and “negative outcomes associated with medication”. The following limits were applied: “humans” and “adults (more than 18 years)”. Results: A total of 59 references were recovered and, after applying inclusion/exclusion criteria, 16 articles were selected. Of these selected articles, 15 provided information on drug-related problems and only 1 on negative outcomes associated with medications. Conclusions: It can be concluded that drug-related problems and negative outcomes associated with medications affect patients with end-stage renal disease, mainly those receiving renal replacement therapy. More evidence is needed, especially on negative outcomes associated with medication. | es_ES |
| dc.description.sponsorship | Office of International Affairs and External Cooperation, University of Costa Rica
OAICE-143-2020 | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | MDPI | es_ES |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | End-stage renal disease | es_ES |
| dc.subject | Medication review | es_ES |
| dc.subject | Drug related problems | es_ES |
| dc.subject | Negative outcomes associated with medication | es_ES |
| dc.title | Medication Review with Follow-Up for End-Stage Renal Disease: Drug-Related Problems and Negative Outcomes Associated with Medication—A Systematic Review | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.3390/jcm12155080 | |
| dc.type.hasVersion | VoR | es_ES |